UMass Announces $250,000 in Technology Development Fund Awards
New technologies aimed at reducing patients’ and health-care workers’ exposure to drug-resistant bacteria, detecting important ocean data, and determining genetic disorders linked to autism and other medical conditions could get closer to market thanks to $250,000 in seed funding announced today by University of Massachusetts President Marty Meehan. Ten faculty research projects will each receive up to $25,000 from the Technology Development Fund, which helps to commercialize scientific breakthroughs throughout the five-campus University of Massachusetts. The fund is overseen by the Office of Technology Commercialization and Ventures (OTCV) at the UMass President’s Office in Boston.